Sonida Senior Living, Inc. (NYSE: SNDA)

Sector: Healthcare Industry: Medical Care Facilities CIK: 0001043000
Market Cap 566.76 Mn
P/B 19.04
P/E -10.87
P/S 1.51
ROIC (Qtr) -3.74
Div Yield % 0.00
Rev 1y % (Qtr) 31.15
Total Debt (Qtr) 684.42 Mn
Debt/Equity (Qtr) 22.99

About

Sonida Senior Living, Inc., or SNDA, is a prominent player in the senior housing industry in the United States. The company specializes in providing a range of senior living services, such as independent living, assisted living, and memory care, for residents aged 75 and older. With a portfolio of 71 communities spread across 18 states, Sonida Senior Living is strategically positioned in attractive, high-growth regions that cater to the growing senior population and the increasing demand for senior living services. The company's revenue is generated...

Read more

Price action

Investment thesis

Bull case

  • Tangible assets of 832.37M provide exceptional 116.84x coverage of deferred revenue 7.12M, showing strong service capability backing.
  • Operating cash flow of 21.63M provides strong 3.04x coverage of deferred revenue 7.12M, indicating service delivery capability.
  • Tangible assets of 832.37M provide robust 10.85x coverage of other current liabilities 76.71M, indicating strong asset backing.
  • Operating cash flow of 21.63M provides strong 100.12x coverage of tax liabilities 216000, showing excellent fiscal position.
  • Cash reserves of 35.92M provide comfortable 166.30x coverage of tax obligations 216000, showing strong fiscal management.

Bear case

  • Operating cash flow of 21.63M barely covers its investment activities of (116.77M), with a coverage ratio of -0.19, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Cash reserves of 35.92M provide limited coverage of acquisition spending of (85.16M), which is -0.42x, suggesting aggressive expansion might strain liquidity if market conditions deteriorate.
  • The company's operating cash flow of 21.63M shows concerning coverage of stock compensation expenses of 4.80M, with a 4.51 ratio indicating potential earnings quality issues.
  • Free cash flow of (9.98M) provides weak coverage of capital expenditures of 31.61M, with a -0.32 ratio suggesting additional external financing needs for growth initiatives.
  • Operating earnings of (7.98M) show weak coverage of depreciation charges of 55.28M, with a -0.14 ratio indicating high capital intensity and potential reinvestment needs.

Peer comparison

Companies in the Medical Care Facilities
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 HCA HCA Healthcare, Inc. 114.88 Bn 18.11 1.54 46.35 Bn
2 THC Tenet Healthcare Corp 18.07 Bn 13.34 0.87 13.19 Bn
3 UHS Universal Health Services Inc 14.64 Bn 10.65 0.86 5.11 Bn
4 FMS Fresenius Medical Care AG 14.10 Bn 16.69 0.61 14.98 Bn
5 EHC Encompass Health Corp 12.55 Bn 19.95 2.17 2.66 Bn
6 ENSG Ensign Group, Inc 10.08 Bn 30.72 2.09 2.16 Bn
7 DVA Davita Inc. 8.90 Bn 11.53 0.67 12.78 Bn
8 CHE Chemed Corp 6.38 Bn 22.87 2.52 0.14 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 1.42 1.26
EV to Cash from Ops. EV/CFO 55.94 12.78
EV to Debt EV to Debt 1.77 12.10
EV to EBIT EV/EBIT -151.52 10.74
EV to EBITDA EV/EBITDA 42.78 16.04
EV to Free Cash Flow [EV/FCF] EV/FCF -121.21 18.02
EV to Market Cap EV to Market Cap 2.14 432.64
EV to Revenue EV/Rev 3.22 2.77
Price to Book Value [P/B] P/B 19.00 -1.92
Price to Earnings [P/E] P/E -10.85 5.13
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Div Coverage (Qtr) -9.25 0.10
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 -13.44
Dividend per Basic Share Div per Share (Qtr) 0.00 0.27
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 5.42
Interest Coverage Int. cover (Qtr) -0.21 -97.94
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) -49.97 -114.65
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) -17.97 65.22
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 0.97
EBIAT Growth (1y) % EBIAT 1y % (Qtr) -130.10 -46.98
EBITDA Growth (1y) % EBITDA 1y % (Qtr) 1.31 75.97
EBIT Growth (1y) % EBIT 1y % (Qtr) -130.56 -61.19
EBT Growth (1y) % EBT 1y % (Qtr) -322.25 -115.48
EPS Growth (1y) % EPS 1y % (Qtr) -62.84 -24.32
FCF Growth (1y) % FCF 1y % (Qtr) 49.29 309.51
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) 22.35 17.88
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 0.44 1.04
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.04
Cash Ratio Cash Ratio (Qtr) 0.35 0.39
Current Ratio Curr Ratio (Qtr) 0.70 1.39
Debt to Equity Ratio Debt/Equity (Qtr) 22.99 -13.19
Interest Cover Ratio Int Coverage (Qtr) -0.21 -97.94
Times Interest Earned Times Interest Earned (Qtr) -0.21 -97.94
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 12.60 -95.81
EBIT Margin % EBIT Margin % (Qtr) -2.13 -94.97
EBT Margin % EBT Margin % (Qtr) -12.31 -105.60
Gross Margin % Gross Margin % (Qtr) 21.50 23.31
Net Profit Margin % Net Margin % (Qtr) -13.90 -106.14